Sartorius Stedim Biotech S.A. (EPA:DIM)
166.00
-0.20 (-0.12%)
Apr 1, 2026, 11:23 AM CET
Sartorius Stedim Biotech Employees
As of December 31, 2025, Sartorius Stedim Biotech had 10,265 total employees, including 9,753 full-time and 512 part-time employees. The number of employees increased by 364 or 3.68% compared to the previous year.
Employees
10,265
Change
364
Growth
3.68%
Revenue / Employee
€296,483
Profits / Employee
€26,536
Market Cap
16.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10,265 | 364 | 3.68% | 9,753 | 512 |
| Sep 30, 2025 | 10,134 | 52 | 0.52% | 10,134 | 0 |
| Jun 30, 2025 | 10,030 | -352 | -3.39% | 10,030 | 0 |
| Mar 31, 2025 | 9,961 | -532 | -5.07% | 9,961 | 0 |
| Dec 31, 2024 | 9,901 | -761 | -7.14% | 9,409 | 492 |
| Sep 30, 2024 | 10,082 | -767 | -7.07% | 10,082 | 0 |
| Jun 30, 2024 | 10,382 | -753 | -6.76% | 10,382 | 0 |
| Mar 31, 2024 | 10,493 | -1,441 | -12.07% | 10,493 | 0 |
| Dec 31, 2023 | 10,662 | -1,272 | -10.66% | 10,662 | 0 |
| Sep 30, 2023 | 10,849 | -1,093 | -9.15% | 10,849 | 0 |
| Jun 30, 2023 | 11,135 | -807 | -6.76% | 11,135 | 0 |
| Dec 31, 2022 | 11,934 | 1,525 | 14.65% | 11,934 | 0 |
| Jun 30, 2022 | 11,942 | 3,196 | 36.54% | 11,942 | 0 |
| Mar 31, 2022 | 11,400 | 3,200 | 39.02% | 11,400 | 0 |
| Dec 31, 2021 | 10,409 | 2,843 | 37.58% | 10,409 | 0 |
| Sep 30, 2021 | 9,619 | 2,640 | 37.83% | 9,619 | 0 |
| Jun 30, 2021 | 8,746 | 2,056 | 30.73% | 8,746 | 0 |
| Mar 31, 2021 | 8,200 | 2,000 | 32.26% | 8,200 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 155,975 |
| emeis Société anonyme | 83,500 |
| Sanofi | 74,846 |
| Clariane SE | 70,685 |
| Eurofins Scientific SE | 65,694 |
| Ramsay Générale de Santé | 40,000 |
| bioMérieux | 15,226 |
| Virbac | 6,365 |
Sartorius Stedim Biotech News
- 8 months ago - Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing - Business Wire
- 8 months ago - Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa - GlobeNewsWire
- 9 months ago - Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible's Unique Cell-Based mRNA Design and Manufacturing Platform - Business Wire
- 1 year ago - Sartorius, Sartorius Stedim Biotech shares jump after results beat - Reuters
- 2 years ago - 10 stocks for investors looking for ‘wonderful companies at a fair price' - Market Watch
- 3 years ago - Sartorius, Sartorius Stedim shares fall after Polyplus acquisition - Market Watch